Amanta Healthcare Ltd.

•

amanta.co.inBSE: 544502NSE: AMANTA

Market Cap₹ 742 Cr.

Current Price

High / Low₹ 206 / 92

Stock P/E50.5

Book Value₹ 58

Price to Book3.37

Dividend Yield0.00 %

ROCE15.2 %

ROE12.9 %

Face Value₹ 10

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence

50%

View full sector analysis →

PROS

Strong cash generation - operating cash flow backs reported profits (CFO/PAT 12.25x)
Institutional investors have been accumulating - FII+DII up 13.3pp
Company generates healthy free cash flow

CONS

Company has a high debt-to-equity of 2.02x
Promoter holding has decreased over last 2 years: -28.5pp
Recent results are weak - TTM profit is down 14.9% versus prior year
Company has a low return on equity of 5.1% over last 3 years
Interest coverage is weak at 1.5x - earnings barely cover interest

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs

Part ofNIFTY 50 NIFTY 500 NIFTY LARGEMIDCAP 250 NIFTY 100 NIFTY 200

S.No.	Name
1.	SUNPHARMA	1904.00	37.77	456833.38	0.84	2901.23	26.53	15299.88	10.98	19.11	28.81
2.	DIVISLAB	9245.00	83.91	245425.70	0.32	902.00	65.50	3080.00	27.80	21.51	40.75
3.	TORNTPHARM	4924.70	85.89	187319.76	0.77	566.00	3.28	4921.00	57.32	19.27	33.81
4.	ZYDUSLIFE	1135.00	25.09	113216.68	0.09	990.20	-34.90	8017.00	23.97	21.39	24.54
5.	CIPLA	1389.00	33.29	112211.54	0.94	785.55	-39.18	7119.28	4.13	16.00	16.73
6.	LAURUSLABS	1872.15	92.52	101154.55	0.11	362.07	123.94	2026.31	29.10	18.20	31.50
7.	LUPIN	2135.00	17.66	97626.26	0.84	1416.98	16.01	8276.89	34.28	28.86	29.59
8.	MANKIND	2345.00	47.42	96859.07	0.04	574.09	29.12	4030.59	12.89	13.24	26.30
9.	DRREDDY	1155.00	29.92	96405.53	0.69	435.60	-69.10	8099.80	-5.21	13.75	10.63
10.	AUROPHARMA	1627.00	25.22	93613.98	0.25	1032.03	25.22	9150.35	17.44	12.76	20.54
11.	GLENMARK	2458.80	38.60	69393.40	0.10	482.83	927.88	4018.48	31.35	20.35	20.03
12.	AMANTA	191.00	50.53	741.64	0.00	3.31	-5.67	68.80	5.35	15.16	21.13

Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	68	67	68	72	65	71	74	77	69
	55	53	53	53	50	56	59	62	65
Operating Profit	13	14	15	19	15	15	15	15	4
OPM %	19.68%	20.80%	22.22%	26.31%	22.81%	20.67%	20.62%	19.43%	5.59%
	0	0	1	0	1	-3	1	2	1
Interest	9	6	6	6	6	5	5	4	6
Depreciation	5	5	5	5	5	5	5	5	5
Profit before Tax	-1	3	6	8	5	2	6	8	4
Tax %	27.45%	28.71%	22.60%	26.87%	28.80%	46.93%	26.67%	27.43%	26.31%
Net Profit	-0	2	4	6	4	1	5	6	3
	-0.13	0.80	1.51	2.11	1.22	0.35	1.35	1.61	0.85

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
	203	211	192	185	184	171	225	259	280	275	291
	161	160	145	144	147	133	172	208	223	215	242
Operating Profit	41	51	46	41	37	38	54	51	57	60	49
OPM %	20.38%	24.27%	24.20%	22.13%	20.27%	22.38%	23.79%	19.64%	20.51%	21.72%	16.77%
	2	1	2	2	2	1	69	5	1	1	0
Interest	14	12	20	41	38	40	44	35	34	28	20
Depreciation	14	15	16	17	16	17	17	18	20	18	19
Profit before Tax	15	25	12	-14	-15	-18	62	3	5	15	21
Tax %	16.98%	7.59%	8.56%	-29.34%	-24.84%	-22.97%	12.79%	178.46%	32.58%	28.60%	29.10%
Net Profit	13	23	11	-19	-19	-22	54	-2	4	11	15
EPS	0.00	0.00	0.00	0.00	-7.04	-8.14	20.08	-0.79	1.35	3.64	—
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	—

COMPOUNDED SALES GROWTH

10 Years:: 5%
5 Years:: 8%
3 Years:: 7%

COMPOUNDED PROFIT GROWTH

10 Years:: 34%
5 Years:: —
3 Years:: -42%

STOCK PRICE CAGR

10 Years:: —
5 Years:: —
3 Years:: —
1 Year:: —

RETURN ON EQUITY

10 Years:: 0%
5 Years:: 9%
3 Years:: 5%
Last Year:: 13%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	37	37	27	27	27	27	27	27	27	29
	110	134	40	21	2	-20	38	36	39	68
	86	76	251	270	277	295	221	220	206	181
Trade Payables	32	35	29	22	17	25	39	36	25	30
	103	108	59	63	64	64	55	55	59	81
Total Liabilities	369	390	406	403	388	392	379	374	355	389
	246	262	267	247	244	242	241	238	228	217
Capital Work in Progress	0	1	2	0	0	0	0	0	0	7
	0	0	0	0	0	2	3	3	4	8
	30	29	34	38	39	57	71	69	59	73
	0	0	0	0	0	0	0	0	48	50
Cash & Bank	6	5	7	13	6	9	10	4	4	3
	86	93	96	104	98	83	54	60	12	31
Total Assets	369	390	406	403	388	392	379	374	355	389

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	43	45	32	39	38	28	64	49	58	47
Cash from Investing	-36	-21	-175	-5	-11	-17	-5	-7	-10	-24
Cash from Financing	-3	-20	152	-21	-35	-17	-52	-42	-46	-23
	0	-0	2	6	-8	-0	6	-6	1	-1

Ratios

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
PER SHARE
EPS (₹)	3.44	6.30	4.26	-6.99	-7.04	-8.14	20.08	-0.79	1.35	3.64
Book Value (₹)	40.02	46.32	24.98	17.88	10.85	2.71	24.22	23.44	24.71	33.43
Dividend per Share (₹)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cash EPS (₹)	7.18	10.27	10.43	-0.82	-0.89	-1.79	26.52	6.05	8.71	10.02
PROFITABILITY
Operating Margin %	19.97%	23.27%	25.09%	23.04%	21.43%	23.00%	24.16%	21.73%	20.51%	21.72%
Net Margin %	5.88%	10.30%	5.84%	-10.14%	-10.24%	-12.75%	23.90%	-0.81%	1.30%	3.82%
ROE %	9.33%	14.59%	9.57%	-32.75%	-48.98%	-120.09%	149.18%	-3.30%	5.63%	12.91%
ROCE %	10.63%	12.69%	10.33%	8.44%	8.27%	8.91%	39.99%	13.43%	14.19%	15.16%
	3.57%	6.10%	2.85%	-4.64%	-4.78%	-5.60%	13.97%	-0.56%	1.00%	2.82%
EFFICIENCY
Debtor Days	79	92	108	105	103	111	78	69	66	65
Inventory Days	57	48	59	71	77	103	104	99	84	88
Payable Days	132	150	171	140	112	157	291	223	159	176
	4	-11	-3	36	68	56	-109	-55	-9	-22
FINANCIAL HEALTH
Debt to Equity (x)	0.49x	0.40x	3.83x	5.18x	7.94x	32.30x	3.41x	3.43x	3.10x	2.02x
Interest Coverage (x)	2.09x	3.04x	1.63x	0.64x	0.60x	0.56x	2.41x	1.08x	1.16x	1.53x
	0.97x	1.00x	1.18x	1.35x	1.43x	1.06x	1.19x	1.35x	1.15x	1.19x
GROWTH
Revenue Growth %	15.92%	4.15%	-9.29%	-3.49%	-0.27%	-7.09%	31.61%	14.94%	8.19%	-2.01%
Operating Profit Growth %	15.84%	21.86%	-7.01%	-12.42%	-7.27%	-0.26%	38.21%	3.40%	4.35%	3.91%
Net Profit Growth %	2198.89%	83.30%	-51.06%	-265.41%	-0.69%	-15.68%	346.78%	-103.92%	272.14%	189.02%
	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	272.14%	168.97%
VALUATION
P/E (x)	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x
P/B (x)	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x
Dividend Yield %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	3.88x	3.61x

Shareholding Pattern

Numbers in percentages

	Dec 2018	Sep 2019	Mar 2020	Mar 2021	Mar 2022	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	92.35	92.52	92.52	92.40	92.59	63.56	63.56	63.72	63.80
	0.00	0.00	0.00	0.00	0.00	1.00	1.10	0.85	0.43
	0.00	0.00	0.00	0.00	0.00	11.34	11.24	12.88	12.92
Government	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	7.65	7.48	7.48	7.60	7.41	24.10	24.10	22.56	22.85

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-03

Copy of Newspaper Publication

2026-09-03 - Amanta Healthcare Limited has informed the Exchange about Copy of Newspaper Publication in respect of special window for transfer and dematerialization requests of physical shares

2026-09-02

General Updates

2026-09-02 - Amanta Healthcare Limited has informed the Exchange about Commissioning of New SteriPort Line

2026-08-25

General Updates

2026-08-25 - Amanta Healthcare Limited has informed the Exchange regarding 'Intimation - Regulation 36(1)(b) of the SEBI Listing Regulations'.

2026-08-25

Copy of Newspaper Publication

2026-08-25 - Amanta Healthcare Limited has informed the Exchange about Copy of Newspaper Publication for dispatch of Annual Report of the 31st Annual General Meeting ( AGM ) and E-Voting Information

2026-08-24

Shareholders meeting

2026-08-24 - Amanta Healthcare Limited has informed the Exchange about Notice of Annual General Meeting to be held on 16th September, 2026

2026-08-12

Copy of Newspaper Publication

2026-08-12 - Amanta Healthcare Limited has informed the Exchange about Copy of Newspaper Publication - Advertisement addressed to Shareholders for Annual General Meeting

2026-08-08

Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-08 - Amanta Healthcare Limited has informed the Exchange about Transcript

2026-08-08

Monitoring Agency Report

2026-08-08 - Monitoring Agency Report for the quarter ended June 30, 2026

2026-08-07

Copy of Newspaper Publication

2026-08-07 - Amanta Healthcare Limited has informed the Exchange about Copy of Newspaper Publication

News

Recent coverage and analyst commentary for AMANTA

Loading news…

🤖

AI Stock Analyst

Amanta Healthcare Ltd.

🔒

Sign in to Chat with AI

✨ Sign In to Chat

Free 5nance Account